BPTH — Bio Path Holdings Balance Sheet
0.000.00%
- $0.62m
- $1.05m
Annual balance sheet for Bio Path Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 13.8 | 23.8 | 10.4 | 1.05 | 1.17 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 16 | 26.1 | 15.6 | 3.04 | 3.78 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.519 | 0.428 | 0.356 | 0.178 | 0.107 |
| Total Assets | 16.5 | 26.6 | 16 | 3.22 | 3.88 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.17 | 0.958 | 1.68 | 1.91 | 3.29 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.41 | 1.11 | 1.8 | 2.78 | 3.73 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 15.1 | 25.5 | 14.2 | 0.441 | 0.154 |
| Total Liabilities & Shareholders' Equity | 16.5 | 26.6 | 16 | 3.22 | 3.88 |
| Total Common Shares Outstanding |